Clinical Trials Browser

Completed × OTHER × trebananib × Clear all

Kidney Neoplasms, Melanoma, Ovarian Neoplasms, Colorectal Neoplasms

NCT01555268 2022-09-13

Trebananib With or Without Low-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT01290263 2017-07-02

Amgen 386 for Recurrent Glioblastoma

Phase 1/2 Completed

48 enrolled 13 charts

CNS

Brain Neoplasms, Glioblastoma, Glioma

Clinical Trials

Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor

Trebananib With or Without Low-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia

Amgen 386 for Recurrent Glioblastoma